文献速递主动脉疾病

基于超声造影的主动脉腔内修复术后随访方案安全有效

Endovascular Aortic Repair Follow up Protocol Based on Contrast Enhanced Ultrasound Is Safe and Effective.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2018-04-17

本研究在三级转诊中心比较了基于超声造影(CEUS)的EVAR随访方案与既往基于CT血管造影(CTA)的随访方案。纳入1999至2015年间接受EVAR且随访至少1年的880例患者,其中A组619例采用平片和双功超声随访,B组261例在特定指征下采用CEUS随访。结果显示CEUS分类内漏的敏感性和特异性均为100%,两组在内漏、再干预和瘤囊缩小百分比方面无差异,且CEUS使CTA使用减少90%。

要点

  • CEUS分类内漏的敏感性和特异性均为100%。
  • 两组4年内内漏、再干预和瘤囊缩小百分比无差异。
  • 引入CEUS后CTA使用减少90%,降低患者辐射暴露。

核心结论

  • 引入基于CEUS的EVAR随访方案安全有效,在中期的内漏识别方面与既往基于CTA的随访方案相似。
  • CEUS使CTA使用减少90%,从而降低患者辐射暴露。

研究设计与样本

  • 三级转诊中心研究,1999-2011年EVAR随访基于平片和双功超声(CDU),CTA仅用于非诊断性影像(A组)。
  • 2012年起,当CDU检出任何内漏、6个月内瘤囊增长>5 mm、肾功能不全(慢性肾脏病3期以上)或碘造影剂过敏时行CEUS(B组)。
  • 纳入1999至2015年间接受EVAR且随访至少1年的880例患者(平均年龄75.6±8.4岁;824例男性)。
  • A组619例(70%),B组261例(30%);中位随访48个月(四分位距24-84)。

主要发现

  • 研究期间共行318次CEUS扫描,无相关并发症。
  • CEUS指征:内漏160次(50%)、显著瘤囊扩张34次(11%)、肾功能不全(慢性肾脏病3期或以上)91次(29%)、碘造影剂过敏33次(10%)。
  • CEUS与CTA比较,前100例中需修复者另经血管造影和手术所见确认;CEUS分类内漏的敏感性和特异性均为100%。
  • 4年时两组内漏、再干预和瘤囊缩小百分比无差异。
  • 4年CTA使用分析发现引入CEUS后减少90%。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of this study was to define the safety and effectiveness of a contrast enhanced ultrasound (CEUS) based follow up for endovascular aortic repair (EVAR) surveillance at a mid-term period (4 years). METHODS: At the tertiary referral centre EVAR surveillance was based on plain abdominal radiograph and duplex ultrasound (CDU), with computed tomography angiography (CTA) reserved for any non-diagnostic imaging during the period 1999-2011 (Group A). From 2012, CEUS was performed when (a) any endoleak was detected at CDU, (b) sac growth > 5 mm within 6 months, and routinely for (c) patients with renal insufficiency (above Stage 3 chronic kidney disease), or (d) iodine contrast allergy (Group B). RESULTS: A total of 880 patients (mean age 75.6 ± 8.4 years; 824 male) who underwent EVAR between 1999 and 2015 and with a minimum of 1 year follow up were included. Six hundred and nineteen patients were in Group A (70%) and the remaining 261 in Group B (30%). Median follow up was 48 months (interquartile range 24-84). During the study period 318 CEUS scans were performed with no related complications. Indications for CEUS were the following: (a) 160 (50%) endoleak presence, (b) 34 (11%) significant sac expansions, (c) 91 (29%) renal insufficiency (Stage 3 or above CKD), and 33 (10%) iodine contrast allergies. CEUS was compared with CTA, with additional confirmation by angiographic and operative findings in the case of repair in the first 100 patients. CEUS had 100% sensitivity and 100% specificity in classifying endoleaks. No differences in endoleak, re-interventions and sac shrinkage percentage were seen between the two groups at 4 years. A 4 year analysis of CTA use found a 90% reduction with the introduction of CEUS. CONCLUSIONS: The introduction of a CEUS based protocol for EVAR follow up was safe and effective and it was similar to the previous CTA based follow up protocol with regard to identification of endoleaks in a mid-term period. Moreover, CEUS allowed for 90% reduction of CTA, thereby decreasing radiation exposure for patients.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Chisci E, Harris L, Guidotti A, et al. Endovascular Aortic Repair Follow up Protocol Based on Contrast Enhanced Ultrasound Is Safe and Effective. Eur J Vasc Endovasc Surg. 2018. PMID: 29673811. doi:10.1016/j.ejvs.2018.03.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。